775d Ustekinumab Versus Adalimumab for Induction and Maintenance Therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE Study
Titel:
775d Ustekinumab Versus Adalimumab for Induction and Maintenance Therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE Study
Auteur:
Sands, Bruce E. Irving, Peter M. Hoops, Timothy Izanec, James L. Gao, Long-Long Gasink, Christopher Greenspan, Andrew Allez, Matthieu Danese, Silvio Hanauer, Stephen B. Jairath, Vipul Kuehbacher, Tanja Lewis, James D. Loftus, Edward V. Mihaly, Emese Panaccione, Remo Scherl, Ellen J. Shchukina, Oksana Sandborn, William J.